Pali Shah M.D.

Assistant Professor of Medicine

Pali Shah is medical director of lung transplantation at Johns Hopkins University. She is a participant and PI within the Cystic Fibrosis Lung Transplant consortium and through this research consortium, has led authorship of CF post transplant care guidelines and led a CFF- learning and leadership collaborative to develop best practices in the transition of CF patients with advanced lung disease to transplant. I currently serve as Hopkins site PI for the Cystic Fibrosis Lung Transplant Consortium and as site PI in CFF funded multi-center study: 'Microbiome and Host response in lung transplant recipients'. In these collaborations, she has immunologic background to craft mechanistic aims that leverage the expertise of 'non-transplant' scientific leaders into the studies relevant to cystic fibrosis patients undergoing lung transplant, thereby enhancing the advancements in our field. Beyond my role with CFF, I am site PI for CTOT -20 and CTOT-22 (Clinical Trials in Organ Transplantation, Palmer) where we conduct mechanistic aims studying CMV immunophenotypes and examine predictors of CLAD. I further served as co- investigator in Lung Transplant Outcomes Group, an R01-funded study of genetic determinants of primary graft dysfunction, and with the NIH (Drs. Valantine) in the Genomic Research Alliance for Transplantation, which examines donor-derived cell free DNA as a marker for lung allograft injury.